Literature DB >> 22938874

The role of the neuromuscular medicine and physiatry specialists in the multidisciplinary management of neuromuscular disease.

Craig M McDonald1, William M Fowler.   

Abstract

The neuromuscular medicine and physiatry specialists are key health care providers who work cooperatively with a multidisciplinary team to provide coordinated care for individuals with neuromuscular diseases (NMDs). The director or coordinator of the team must be aware of the potential issues specific to NMDs and be able to access the interventions that are the foundations for proper care in NMD. Ultimate goals include maximizing health and functional capacities, performing medical monitoring and surveillance to inhibit and prevent complications, and promoting access and full integration into the community to optimize quality of life.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2012        PMID： 22938874      PMCID： PMC3482408          DOI： 10.1016/j.pmr.2012.06.010

Source DB:  PubMed          Journal:  Phys Med Rehabil Clin N Am        ISSN： 1047-9651            Impact factor:   1.784


  71 in total

Review 1.  Quality of life. Issues for persons with neuromuscular diseases.

Authors:  R T Abresch; N K Seyden; M A Wineinger
Journal:  Phys Med Rehabil Clin N Am       Date:  1998-02       Impact factor: 1.784

2.  Profiles of neuromuscular diseases. Design of the protocol.

Authors:  W M Fowler; R T Abresch; S Aitkens; G T Carter; E R Johnson; D D Kilmer; M A McCrory; N C Wright
Journal:  Am J Phys Med Rehabil       Date:  1995 Sep-Oct       Impact factor: 2.159

3.  Pulmonary function tests in children.

Authors:  G Polgar
Journal:  J Pediatr       Date:  1979-07       Impact factor: 4.406

Review 4.  Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management.

Authors:  Katharine Bushby; Richard Finkel; David J Birnkrant; Laura E Case; Paula R Clemens; Linda Cripe; Ajay Kaul; Kathi Kinnett; Craig McDonald; Shree Pandya; James Poysky; Frederic Shapiro; Jean Tomezsko; Carolyn Constantin
Journal:  Lancet Neurol       Date:  2009-11-27       Impact factor: 44.182

5.  Managing Duchenne muscular dystrophy--the additive effect of spinal surgery and home nocturnal ventilation in improving survival.

Authors:  Michelle Eagle; John Bourke; Robert Bullock; Mike Gibson; Jwalant Mehta; Dave Giddings; Volker Straub; Kate Bushby
Journal:  Neuromuscul Disord       Date:  2007-05-08       Impact factor: 4.296

6.  Thoracic kyphosis: range in normal subjects.

Authors:  G T Fon; M J Pitt; A C Thies
Journal:  AJR Am J Roentgenol       Date:  1980-05       Impact factor: 3.959

7.  Hand function and disability of the arm, shoulder and hand in Charcot-Marie-Tooth disease.

Authors:  Elsine Eklund; Elisabeth Svensson; Charlotte Häger-Ross
Journal:  Disabil Rehabil       Date:  2009       Impact factor: 3.033

8.  Maximal static respiratory pressures in children and adolescents.

Authors:  R Domènech-Clar; J A López-Andreu; L Compte-Torrero; A De Diego-Damiá; V Macián-Gisbert; M Perpiñá-Tordera; J M Roqués-Serradilla
Journal:  Pediatr Pulmonol       Date:  2003-02

9.  Reliability of the North Star Ambulatory Assessment in a multicentric setting.

Authors:  E S Mazzone; S Messina; G Vasco; M Main; M Eagle; A D'Amico; L Doglio; L Politano; F Cavallaro; S Frosini; L Bello; F Magri; A Corlatti; E Zucchini; B Brancalion; F Rossi; M Ferretti; M G Motta; M R Cecio; A Berardinelli; P Alfieri; T Mongini; A Pini; G Astrea; R Battini; G Comi; E Pegoraro; L Morandi; M Pane; C Angelini; C Bruno; M Villanova; G Vita; M A Donati; E Bertini; E Mercuri
Journal:  Neuromuscul Disord       Date:  2009-06-23       Impact factor: 4.296

10.  Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance.

Authors: 
Journal:  Health Qual Life Outcomes       Date:  2006-10-11       Impact factor: 3.186
View more
  5 in total

Review 1.  Optimizing Bone Health in Duchenne Muscular Dystrophy.

Authors:  Jason L Buckner; Sasigarn A Bowden; John D Mahan
Journal:  Int J Endocrinol       Date:  2015-06-01       Impact factor: 3.257

2.  Effects of lumbar lordosis increment on gait deteriorations in ambulant boys with Duchenne Muscular Dystrophy: A cross-sectional study.

Authors:  Meral Bilgilisoy Filiz; Naciye Füsun Toraman; Muhammet Gültekin Kutluk; Serkan Filiz; Şebnem Koldaş Doğan; Tuncay Çakır; Aylin Yaman
Journal:  Braz J Phys Ther       Date:  2021-05-24       Impact factor: 3.377

3.  The 6-Minute Walk Test and Person-Reported Outcomes in Boys with Duchenne Muscular Dystrophy and Typically Developing Controls: Longitudinal Comparisons and Clinically-Meaningful Changes Over One Year.

Authors:  Erik Henricson; Richard Abresch; Jay J Han; Alina Nicorici; Erica Goude Keller; Evan de Bie; Craig M McDonald
Journal:  PLoS Curr       Date:  2013-07-08

4.  The 6-minute walk test and other clinical endpoints in duchenne muscular dystrophy: reliability, concurrent validity, and minimal clinically important differences from a multicenter study.

Authors:  Craig M McDonald; Erik K Henricson; R Ted Abresch; Julaine Florence; Michelle Eagle; Eduard Gappmaier; Allan M Glanzman; Robert Spiegel; Jay Barth; Gary Elfring; Allen Reha; Stuart W Peltz
Journal:  Muscle Nerve       Date:  2013-07-17       Impact factor: 3.217

5.  Management of motor rehabilitation in individuals with muscular dystrophies. 1st Consensus Conference report from UILDM - Italian Muscular Dystrophy Association (Rome, January 25-26, 2019).

Authors:  Maria Elena Lombardo; Elena Carraro; Cristina Sancricca; Michela Armando; Michela Catteruccia; Elena Mazzone; Giulia Ricci; Ferdinando Salamino; Filippo Maria Santorelli; Massimiliano Filosto
Journal:  Acta Myol       Date:  2021-06-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.